Literature DB >> 1680245

Relative efficacy of drugs for the treatment of sleepiness in narcolepsy.

M M Mitler1, R Hajdukovic.   

Abstract

A survey was conducted on 10 polysomnographic studies on the pharmacologic treatment of the sleepiness of narcolepsy. Three studies employed the MSLT and 7 employed the MWT as their polygraphic measure of sleep tendency. Statistically and clinically significant therapeutic changes were apparent for pemoline, modafinil, dextroamphetamine and methylphenidate. Codeine, ritanserin and protriptyline did show statistically significant effects. The common feature among the drugs that did produce clinically significant improvements seems to be facilitatory action on central catecholaminergic transmission. Within this group of drugs, only methylphenidate and dextroamphetamine brought MWT sleep latencies to approximately 70% of normal levels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680245      PMCID: PMC2246380          DOI: 10.1093/sleep/14.3.218

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  6 in total

1.  Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness.

Authors:  M A Carskadon; W C Dement; M M Mitler; T Roth; P R Westbrook; S Keenan
Journal:  Sleep       Date:  1986-12       Impact factor: 5.849

2.  Maintenance of wakefulness test: a polysomnographic technique for evaluation treatment efficacy in patients with excessive somnolence.

Authors:  M M Mitler; K S Gujavarty; C P Browman
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1982-06

3.  The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study.

Authors:  L Scrima; P G Hartman; F H Johnson; E E Thomas; F C Hiller
Journal:  Sleep       Date:  1990-12       Impact factor: 5.849

4.  Treatment of narcolepsy with codeine.

Authors:  J M Fry; M R Pressman; M A DiPhillipo; M Forst-Paulus
Journal:  Sleep       Date:  1986       Impact factor: 5.849

5.  Excessive daytime sleepiness in man: multiple sleep latency measurement in narcoleptic and control subjects.

Authors:  G S Richardson; M A Carskadon; W Flagg; J Van den Hoed; W C Dement; M M Mitler
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1978-11

6.  Narcolepsy.

Authors:  M M Mitler; R Hajdukovic; M Erman; J A Koziol
Journal:  J Clin Neurophysiol       Date:  1990-01       Impact factor: 2.177

  6 in total
  16 in total

Review 1.  Potential adverse effects of amphetamine treatment on brain and behavior: a review.

Authors:  S M Berman; R Kuczenski; J T McCracken; E D London
Journal:  Mol Psychiatry       Date:  2008-08-12       Impact factor: 15.992

2.  Effects of Pharmacotherapy Treatment on Patient-Reported Outcomes in a Narcolepsy and Idiopathic Hypersomnia Cohort.

Authors:  Maeve Pascoe; James Bena; Nancy Foldvary-Schaefer
Journal:  J Clin Sleep Med       Date:  2019-10-30       Impact factor: 4.062

3.  Pharmacokinetics and pharmacodynamics of methylphenidate enantiomers in rats.

Authors:  T Aoyama; H Kotaki; Y Sawada; T Iga
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

4.  Pharmacodynamic modeling for change of locomotor activity by methylphenidate in rats.

Authors:  T Aoyama; K Yamamoto; H Kotaki; Y Sawada; T Iga
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

5.  Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy.

Authors:  K J McClellan; C M Spencer
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

Review 6.  Benefits and risks of pharmacotherapy for narcolepsy.

Authors:  Merrill M Mitler; Roza Hayduk
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

7.  Treatment of narcolepsy with methamphetamine.

Authors:  M M Mitler; R Hajdukovic; M K Erman
Journal:  Sleep       Date:  1993-06       Impact factor: 5.849

Review 8.  Narcolepsy in the older adult: epidemiology, diagnosis and management.

Authors:  Sangeeta S Chakravorty; David B Rye
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

9.  Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers.

Authors:  E Mignot; A Renaud; S Nishino; J Arrigoni; C Guilleminault; W C Dement
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Modafinil in the treatment of excessive sleepiness.

Authors:  Jonathan R L Schwartz
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.